The goal of this clinical trial is to develop and test an app designed to reduce suicide risk and improve emotional well-being in adolescents. The study will test if the app's daily check ins and recommended mood boosting skills will improve the adolescent's overall mood and suicidality. The main question it aims to answer is:
• Is the app practical and acceptable to use daily?
In the study, adolescents will:
* Participate in a focus group with other adolescents and provide feedback on the app itself (design, ease of use, etc.). * Complete surveys and assessments on their mood, thoughts, and experiences. * Complete assessments about their app experience.
In the study, the legal guardian of the adolescent will:
* Participate in a focus group with other adolescents and provide feedback on the app itself (design, ease of use, etc.). * Complete assessments about their app experience.
Aged 13-17 years old
Recent suicidal ideation
Access to a smartphone device
Residing in the Philadelphia metropolitan area
Psychotic disorder, including schizophrenia, schizoaffective disorder, or psychotic disorder not otherwise specified, with a past year psychotic episode prior to baseline
Bipolar disorder I diagnosis, with a past year manic episode prior to baseline
Imminent suicide risk (e.g., active suicidal ideation with a specific plan and intent)
Single group
Suicide prevention treatment
BehavioralDigital just-in-time adaptive intervention to enhance reward sensitivity and reduce suicidal ideation
Acceptability of Digital Suicide Prevention Intervention
At least 80% of youth will report in qualitative feedback that the digital suicide prevention intervention is helpful and relevant to their daily lives.
Usability of Digital Suicide Prevention Intervention
The digital suicide prevention intervention prototype will exceed established usability benchmarks, as measured by the System Usability Scale (SUS; range = 0-100, with higher scores indicating greater perceived usability), with a mean SUS score of at least 70.
Click on the lead sponsor to view all of their trials.
